Study of MVA Protein 183 and Its Functionality
Author Information
Author(s): Laura E. McCoy, Aodhnait S. Fahy, Ron A.-J. Chen, Geoffrey L. Smith
Primary Institution: Imperial College London
Hypothesis
Deletion of gene 183R might increase MVA immunogenicity and increase its potency as a vaccine.
Conclusion
MVA protein 183 is a non-functional counterpart of VACV WR protein B14 and does not contribute to virulence or inhibit NF-κB activation.
Supporting Evidence
- MVA protein 183 shares 95% amino acid identity with B14 but is unstable and non-functional.
- 183 did not inhibit NF-κB activation in response to cytokine stimulation.
- Insertion of 183R into a virus did not alter lesion size in a mouse model.
Takeaway
The study found that a protein in a vaccine virus is not working as it should, which might affect how well the vaccine works.
Methodology
The study involved transfecting cells with plasmids and assessing NF-κB activation through luciferase assays.
Limitations
The study primarily focused on a specific protein and its functionality, which may not represent the entire vaccine's effectiveness.
Participant Demographics
Groups of female C57Bl/6 mice, between 6 and 8 weeks old.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website